Could remdesivir be a game changer for COVID patients? Experts say wait for dataOne U.S. study found recovery in patients using the drug was shortened by 31%—11 days on average versus 15 days for those just given usual care Ontario and B.C. data find drop in people seeking care for serious heart attacks First oral GLP-1 receptor agonist for type 2 diabetes reaches Canadian market Novo Nordisk introduces Rybelsus, an oral formulation of semaglutide Western scientists classify COVID-19 virus DNA using machine learning Canadian technology used to assess stem cell therapy for COVID-19 Science summary: A look at novel coronavirus research around the globe What can countries learn from Hong Kong's response to the COVID-19 pandemic? Feds to announce new measures to mobilize scientists in COVID-19 fight Science summary: A look at novel coronavirus research in Canada and around the globe Oncology drugs are largest category in pipeline, review board reports First Previous 248 249 250 251 252 Next Last
